ORAL ONCOLOGY

metrics 2024

Elevating Standards in Oncology and Oral Health

Introduction

ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.

Metrics 2024

SCIMAGO Journal Rank1.26
Journal Impact Factor4.00
Journal Impact Factor (5 years)4.60
H-Index137
Journal IF Without Self4.00
Eigen Factor0.01
Normal Eigen Factor2.68
Influence1.20
Immediacy Index0.70
Cited Half Life6.80
Citing Half Life6.10
JCI1.18
Total Documents5721
WOS Total Citations13287
SCIMAGO Total Citations48769
SCIMAGO SELF Citations4036
Scopus Journal Rank1.26
Cites / Document (2 Years)2.25
Cites / Document (3 Years)2.63
Cites / Document (4 Years)2.99

Metrics History

Rank 2024

Scopus

Oral Surgery in Dentistry
Rank #1/74
Percentile 98.65
Quartile Q1
Oncology in Medicine
Rank #71/404
Percentile 82.43
Quartile Q1
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #66/230
Percentile 71.30
Quartile Q2

IF (Web Of Science)

DENTISTRY, ORAL SURGERY & MEDICINE
Rank 13/157
Percentile 92.00
Quartile Q1
ONCOLOGY
Rank 95/322
Percentile 70.70
Quartile Q2

JCI (Web Of Science)

DENTISTRY, ORAL SURGERY & MEDICINE
Rank 30/157
Percentile 80.89
Quartile Q1
ONCOLOGY
Rank 62/322
Percentile 80.75
Quartile Q1

Quartile History

Similar Journals

World Journal of Clinical Oncology

Fostering Collaboration in the Fight Against Cancer
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 2218-4333Frequency: 12 issues/year

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.

JOURNAL OF SURGICAL ONCOLOGY

Elevating Patient Care through Surgical Insights
Publisher: WILEYISSN: 0022-4790Frequency: 16 issues/year

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

International Journal of Clinical Oncology

Driving Progress in Clinical Practices and Research
Publisher: SPRINGER JAPAN KKISSN: 1341-9625Frequency: 6 issues/year

International Journal of Clinical Oncology, published by SPRINGER JAPAN KK, is a leading peer-reviewed journal dedicated to advancing research and clinical practices in the fields of oncology, hematology, and surgery. With its impact factor reflecting its significance and reach in the academic community, this journal serves as a solid platform for researchers, professionals, and students to share and disseminate groundbreaking discoveries and methodologies. Notably, it has secured prestigious rankings in the Q1 category in Medicine (miscellaneous) and Surgery, and Q2 in Hematology and Oncology, illustrating its prominent position in the medical literature. The journal's comprehensive scope addresses pivotal clinical issues from 1996 through 2024, further solidifying its relevance in the ever-evolving landscape of cancer research. Despite not offering open access, the depth and quality of research articles ensure that vital information remains accessible to those committed to improving clinical outcomes in oncology. With a focus on innovative treatments and patient care, the International Journal of Clinical Oncology embodies a commitment to fostering excellence in medical research.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Exploring innovative techniques for better patient outcomes.
Publisher: CHURCHILL LIVINGSTONEISSN: 0901-5027Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY is a premier peer-reviewed journal published by Churchill Livingstone, dedicated to advancing the field of oral and maxillofacial surgery. With an impressive Q1 ranking in the categories of Oral Surgery, Otorhinolaryngology, and Surgery as of 2023, this journal serves as a vital resource for researchers, clinicians, and students alike, offering cutting-edge research findings, clinical studies, and innovative surgical techniques. The journal covers a wide range of topics within its scope, ensuring that it remains at the forefront of advancements in surgical practice and patient care. Though it operates under a traditional access model, its Impact Factor reflects its significance in the field and its role in disseminating critical knowledge. Established in 1986, the INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY continues to be an essential tool for those dedicated to enhancing therapeutic outcomes and surgical methodologies, solidifying its position as a trusted resource in the ongoing evolution of maxillofacial sciences.

Journal of Oral and Maxillofacial Surgery Medicine and Pathology

Elevating Standards in Oral and Maxillofacial Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 2212-5558Frequency: 6 issues/year

Journal of Oral and Maxillofacial Surgery Medicine and Pathology, published by Elsevier Science Inc, serves as a vital resource in the multidisciplinary field of oral and maxillofacial surgery, pathology, and related medical disciplines. With an ISSN of 2212-5558 and an E-ISSN of 2212-5566, this journal plays a pivotal role in advancing knowledge and practices from 2012 to 2024. Recognized for its rigorous peer-review process and quality contributions, it has achieved notable rankings in various categories, including Q3 in Oral Surgery and Q3 in Otorhinolaryngology as of 2023. Although the journal does not currently offer an open access option, it remains a key platform for publishing innovative research that enhances patient care and surgical techniques. This journal is an essential read for researchers, clinicians, and students dedicated to the fields of dentistry, pathology, and surgical medicine, ensuring that they remain at the forefront of community advancements and clinical developments.

ARCHIVES OF ORAL BIOLOGY

Elevating Oral Biology Through Rigorous Research
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0003-9969Frequency: 12 issues/year

The Archives of Oral Biology, published by Pergamon-Elsevier Science Ltd, is a prestigious journal that has been at the forefront of oral biology research since its inception in 1959. With a focus on advancing knowledge in the fields of cell biology, dentistry, and otorhinolaryngology, this journal serves as a critical platform for disseminating innovative research findings, spanning from fundamental scientific studies to clinical applications. The journal enjoys a respectable impact factor, with notable rankings in various categories, including Q2 in Dentistry and Otorhinolaryngology, making it highly relevant for professionals and researchers alike. Though not open access, the Archives of Oral Biology continues to attract high-quality submissions and remains an influential source of information for the global scientific community, contributing significantly to the understanding of oral health and disease.

Translational Oncology

Innovating Tomorrow's Cancer Therapies Today
Publisher: ELSEVIER SCIENCE INCISSN: 1936-5233Frequency: 6 issues/year

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

SEMINARS IN RADIATION ONCOLOGY

Connecting Researchers and Clinicians for Better Outcomes
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1053-4296Frequency: 4 issues/year

SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.

Molecular and Clinical Oncology

Advancing cancer research for a healthier tomorrow.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

Clinical Lung Cancer

Empowering clinicians with cutting-edge lung cancer studies.
Publisher: CIG MEDIA GROUP, LPISSN: 1525-7304Frequency: 6 issues/year

Clinical Lung Cancer is a prestigious journal published by CIG MEDIA GROUP, LP, dedicated to advancing the field of oncology and pulmonary medicine since its establishment in 2000. With an impressive impact factor and high ranking within its fields—achieving Q1 status in Oncology and Pulmonary and Respiratory Medicine in 2023—this journal serves as a vital resource for researchers, clinicians, and students alike. Covering a wide scope of topics related to lung cancer, Clinical Lung Cancer offers a platform for innovative studies, clinical trials, and comprehensive reviews that contribute to both theory and practice. While it operates on a subscription basis, the quality of content is reflected in its ranked status within the top quartile of cancer research journals. This journal plays a critical role in shaping the future of lung cancer research and treatment, making it an essential destination for those looking to stay at the forefront of the field.